ReviewClinical & translational immunology2021

RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?

Ingrid Carvacho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.